Full Text
The primary objective of this experimental study was to perform a comprehensive morphological evaluation of ischemic injury affecting the optic nerve and associated retinal structures following experimentally induced vascular insufficiency. The investigation aimed to characterize sequential histopathological alterations occurring during acute and subacute stages of ischemia, quantify neuronal and axonal degeneration, evaluate inflammatory responses, determine the degree of myelin destruction, assess vascular abnormalities, and analyze ultrastructural changes using advanced microscopic techniques. A further objective was to identify morphological biomarkers that accurately reflect the severity of ischemic injury and may serve as objective indicators for evaluating future neuroprotective therapeutic interventions.
2. Materials and Methods
The investigation was carried out using healthy adult Wistar rats weighing between 220 and 280 grams. Animals were maintained under standardized laboratory conditions with controlled temperature, humidity, and twelve-hour light-dark cycles while receiving unrestricted access to food and drinking water throughout the study period. All experimental procedures complied with internationally accepted ethical guidelines governing laboratory animal research and were approved by the institutional ethics committee before initiation of the experiment.
Experimental optic nerve ischemia was induced by transient elevation of intraocular pressure to a level sufficient to interrupt optic nerve perfusion without producing irreversible mechanical disruption of ocular tissues. General anesthesia was administered before all procedures to minimize pain and physiological stress. Intraocular pressure was maintained for sixty minutes before gradual reperfusion was established. Control animals underwent identical anesthetic and handling procedures without induction of ischemia.
Animals were euthanized at predetermined intervals of 24 hours, 72 hours, and 7 days following reperfusion to evaluate the temporal progression of morphological alterations. Both optic nerves and retinal tissues were immediately harvested and immersed in 10% neutral buffered formalin for fixation. Following fixation, tissues were dehydrated through graded ethanol solutions, cleared in xylene, embedded in paraffin, sectioned into five-micrometer slices, and mounted on glass slides for microscopic evaluation.
Routine histological examination was performed using hematoxylin and eosin staining to evaluate overall tissue architecture, cellular morphology, edema, hemorrhage, inflammatory infiltration, and vascular changes. Luxol Fast Blue staining was employed to assess the integrity of myelin sheaths and determine the extent of demyelination. Cresyl violet staining was used for identification and quantitative assessment of surviving retinal ganglion cells.
Immunohistochemical analysis was conducted using antibodies against glial fibrillary acidic protein (GFAP) to evaluate astrocytic activation, ionized calcium-binding adaptor molecule-1 (Iba-1) to identify activated microglia, cleaved caspase-3 as an indicator of apoptosis, tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) to assess inflammatory activity, and hypoxia-inducible factor-1 alpha (HIF-1α) as a marker of tissue hypoxia. Positive immunoreactivity was quantified using computerized image analysis software.
For ultrastructural evaluation, selected tissue specimens were fixed in glutaraldehyde, post-fixed in osmium tetroxide, embedded in epoxy resin, and processed for transmission electron microscopy. Ultrastructural examination focused on mitochondrial morphology, integrity of myelin lamellae, neurofilament organization, endothelial cell morphology, synaptic vesicles, and nuclear architecture.
Morphometric analysis included measurement of optic nerve diameter, axonal density, axonal cross-sectional area, myelin thickness, retinal ganglion cell density, inflammatory cell counts, vascular lumen diameter, and glial scar formation.
Microscopic examination demonstrated that experimentally induced ischemia produced extensive structural alterations throughout the optic nerve and retina. Within the first twenty-four hours after ischemia, optic nerve fibers exhibited pronounced intracellular edema accompanied by significant swelling of axons and disruption of normal fascicular organization. Blood vessels demonstrated marked congestion with narrowing of capillary lumens and endothelial swelling. Small perivascular hemorrhages were occasionally observed in severely affected specimens. The extracellular space became expanded due to accumulation of tissue fluid, indicating the development of vasogenic edema.
Histological sections stained with hematoxylin and eosin demonstrated progressive degeneration of neuronal tissue characterized by vacuolar degeneration, fragmentation of axonal profiles, and disorganization of connective tissue septa. Luxol Fast Blue staining revealed early disruption of compact myelin with irregular staining intensity, indicating initial stages of demyelination. These alterations became increasingly prominent as the duration of ischemia increased.
Quantitative morphometric analysis revealed a statistically significant reduction in axonal density compared with control specimens. Surviving axons frequently exhibited irregular contours, variable diameters, and fragmentation of cytoskeletal elements. Retinal examination demonstrated a progressive decline in retinal ganglion cell density accompanied by condensation of nuclear chromatin and cytoplasmic shrinkage, both characteristic features of apoptosis.
The present experimental investigation demonstrates that ischemia produces complex and progressive morphological alterations involving neuronal, glial, vascular, and connective tissue components of the optic nerve. The findings indicate that ischemic injury is not limited to transient oxygen deprivation but instead initiates a sequence of interconnected pathological events that continue long after blood flow has been restored. These secondary mechanisms substantially contribute to irreversible degeneration of the visual pathway.
One of the earliest consequences of ischemia observed in this study was intracellular edema associated with axonal swelling. This phenomenon reflects disruption of membrane ion transport caused by depletion of intracellular ATP. Failure of sodium-potassium ATPase activity allows excessive accumulation of sodium ions within neurons, resulting in osmotic water influx and cellular swelling. Persistent edema compresses surrounding capillaries, further reducing tissue perfusion and aggravating local hypoxia. Consequently, a self-perpetuating cycle develops in which ischemia promotes edema, and edema further intensifies ischemic injury.
The marked degeneration of retinal ganglion cells observed during the experiment represents one of the most clinically significant findings. Retinal ganglion cells constitute the sole neuronal population responsible for transmitting visual information from the retina to the brain through the optic nerve. Their loss therefore results in permanent interruption of visual signal conduction. The increased expression of cleaved caspase-3 indicates that apoptosis rather than necrosis is the predominant mechanism responsible for neuronal death during the early stages of ischemia. Because apoptotic pathways evolve gradually, they provide an important therapeutic target for interventions designed to preserve neuronal survival before irreversible degeneration occurs.
Reactive gliosis constituted another prominent feature of ischemic injury. Astrocytes became strongly activated, as demonstrated by increased GFAP expression, and formed dense networks surrounding damaged axons. Initially, astrocyte activation may provide protective functions by stabilizing extracellular ion concentrations, limiting excitotoxicity, and supporting metabolic recovery. However, prolonged astrocyte proliferation ultimately contributes to glial scar formation, creating both physical and biochemical barriers that inhibit axonal regeneration. These observations emphasize the dual role of astrocytes in both tissue protection and chronic neurodegeneration.
Activation of microglial cells further illustrates the importance of neuroinflammation in ischemic optic nerve injury. Although activated microglia participate in removal of cellular debris and release neurotrophic molecules during the acute phase of injury, persistent activation promotes secretion of pro-inflammatory cytokines, reactive oxygen species, nitric oxide, and proteolytic enzymes that amplify secondary neuronal damage. The increased expression of inflammatory mediators observed in this study supports the concept that prolonged inflammation significantly contributes to disease progression.
Ultrastructural examination identified mitochondria as one of the principal targets of ischemic injury. Mitochondrial swelling and disruption of cristae impair oxidative phosphorylation and ATP synthesis while simultaneously increasing production of reactive oxygen species. Oxidative stress damages membrane lipids, structural proteins, and genomic DNA, accelerating neuronal degeneration. Preservation of mitochondrial integrity therefore represents a promising therapeutic strategy for limiting ischemic injury.
Experimental ischemia induces widespread structural, cellular, and ultrastructural damage throughout the optic nerve and retina. The pathological process is characterized by progressive axonal degeneration, retinal ganglion cell apoptosis, disruption of myelin architecture, mitochondrial dysfunction, vascular impairment, inflammatory activation, and reactive gliosis. These alterations increase in severity with prolonged ischemia and collectively contribute to irreversible loss of visual function.
Comprehensive morphological evaluation using histopathological staining, immunohistochemistry, morphometric analysis, and transmission electron microscopy provides highly reliable information regarding the extent and progression of ischemic injury. The combination of qualitative and quantitative assessment enables precise characterization of neuronal degeneration and serves as an effective approach for evaluating experimental models of ischemic optic neuropathy.
The results emphasize that ischemic optic nerve injury is a multifactorial disorder involving complex interactions among vascular insufficiency, oxidative stress, excitotoxicity, inflammation, apoptosis, and glial activation. Understanding these interconnected mechanisms is essential for the development of effective neuroprotective and regenerative therapies. Future research should focus on identifying early morphological biomarkers of injury, improving preservation of retinal ganglion cells, maintaining microvascular integrity, reducing secondary inflammatory damage, and promoting axonal regeneration. Such advances may contribute to the development of innovative treatment strategies capable of preserving visual function and improving the prognosis of patients affected by ischemic optic neuropathy.
[1]Hayreh SS. Ischemic Optic Neuropathies. Progress in Retinal and Eye Research. 2009;28(1):34-62.
[2]Levin LA, Nilsson SFE, Ver Hoeve J, Wu SM, Kaufman PL, Alm A. Adler's Physiology of the Eye. 11th ed. Elsevier; 2011.
[3]Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. 9th ed. Elsevier; 2020.
[4]Yanoff M, Duker JS. Ophthalmology. 5th ed. Elsevier; 2019.
[5]Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed. Lippincott Williams & Wilkins; 2005.
[6]Osborne NN, Melena J, Chidlow G, Wood JPM. A Hypothesis to Explain Ganglion Cell Death Caused by Vascular Insults at the Optic Nerve Head: Possible Implication for Glaucoma. British Journal of Ophthalmology. 2001;85(10):1252-1259.
[7]Osborne NN, Casson RJ, Wood JPM, Chidlow G, Graham M, Melena J. Retinal Ischemia: Mechanisms of Damage and Potential Therapeutic Strategies. Progress in Retinal and Eye Research. 2004;23(1):91-147.
[8]Cioffi GA. Ischemic Model of Optic Nerve Injury. Transactions of the American Ophthalmological Society. 2005;103:592-613.
[9]Sadun AA, Wang MY. Optic Nerve Injury and Regeneration. Current Opinion in Ophthalmology. 2008;19(6):502-506.
[10]Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review. JAMA. 2014;311(18):1901-1911.
[11]Quigley HA. Neuronal Death in Glaucoma. Progress in Retinal and Eye Research. 1999;18(1):39-57.
[12]Levin LA. Neuroprotection in Optic Neuropathy. Asia-Pacific Journal of Ophthalmology. 2018;7(4):246-250.